Abiopharma

News list

📋 Medine GmbH (Officer) plans to sell 858K shares of BioNTech SE (at $103.81 each, total $89.1M) Filed: Sep 03, 2026 | ID: 000012

Full text

News bot Sept. 3, 2026, 12:04 p.m.
📋 Form 144 Filing: Medine GmbH

Company: BioNTech SE

Filing Date: 2026-09-03

Relationship: Officer; 10% Stockholder
Planned Sale Details:
- Security: American Depositary Shares representing ordinary shares, no par value per share
- Shares to be Sold: 858,209
- Price per Share: $103.81
- Total Value: $89,090,676.29
- Planned Sale Date: 2026-09-03
- Broker: Berenberg Capital Markets LLC
- Exchange: Nasdaq Global Select
Additional Information:
- SEC File Number: 001-39081
- Issuer Contact Phone: 0049613190840
- Issuer Address: AN DER GOLDGRUBE 12, MAINZ, 2M, 55131
- Broker Address: 1251 Avenue of the Americas, 53rd Floor, New York, NY, 10020
- Shares Outstanding: 251204366.0
- Number of Securities to be Sold: 2
- Remarks: The filing of this Form 144 shall not be construed as an admission that the undersigned is an affiliate of the issuer.
- Signature: /s/ Ugur Sahin